The short answer
- MS is not an automatic decline - relapsing-remitting disease is insurable.
- The type matters more than anything else on the application.
- Mobility and relapse frequency are weighed above the diagnosis date.
- Progressive forms move most applicants toward simplified or guaranteed issue.
Where you stand
Relapsing-remitting MS is insurable
The most common form of MS, with stable function and few relapses, is written at a rating by a number of carriers. It is the progressive forms, and significant mobility loss, that narrow the field.
Check my options →What decides your rate
MS underwriting is unusually individual, because two people with the same diagnosis can have very different function:
- The type - relapsing-remitting, secondary progressive or primary progressive
- Time since diagnosis - a longer stable history is strongly in your favour
- Relapse frequency - how many, how recent, and how fully you recovered
- Current function - mobility, whether you work, whether you need aids
- Disease-modifying therapy - being on treatment and stable helps your case
What each situation typically means
| Type and function | Realistic route |
|---|---|
| Relapsing-remitting, 2+ years stable, full mobility | Table rating |
| Relapsing-remitting, occasional relapses, on therapy | Heavier table rating |
| Recently diagnosed, not yet stabilised | Postpone |
| Secondary progressive | Substandard or simplified issue |
| Primary progressive | Simplified or guaranteed issue |
| Significant mobility impairment | Guaranteed issue |
Time since diagnosis works for you
MS is one of the conditions where waiting can genuinely improve your offer. A newly diagnosed applicant is often postponed simply because there is no track record yet. Two or three documented years of stable function, with few or no relapses, turns the same person into a straightforward rated case.
Why the type decides so much
Relapsing-remitting MS follows a pattern of flares and recovery, and many people live with it for decades with good function. Underwriters can price that. Progressive forms accumulate disability steadily, which is a materially different mortality picture, and the offers reflect it.
If you do not know which type you have been diagnosed with, that is the first thing to establish before anyone applies on your behalf.
Function matters more than the label
Two applicants can both have relapsing-remitting MS and get very different answers. What separates them is function: whether you still work, whether you walk unaided, how completely you recover from a relapse.
This is also why an informal pre-screen is worth more here than on almost any other condition. Carriers differ sharply on MS, and a decline is disclosable on every future application you ever make.
The order to apply
- Confirm your MS type from your neurologist records
- Document your relapse history and how fully you recovered
- Record your current function - work, mobility, daily independence
- Have an agent pre-screen several carriers informally before applying anywhere
Common questions
Can you get life insurance with multiple sclerosis?+
Yes. Relapsing-remitting MS with stable function and few relapses is written by a number of carriers at a rating. Progressive forms and significant mobility loss narrow the options, but guaranteed issue remains available to everyone.
Is MS an automatic decline for life insurance?+
No. It was treated far more harshly in the past, but relapsing-remitting disease with a stable history is a normal rated application today. The outcome depends on type, relapse frequency and current function.
Should I wait before applying after an MS diagnosis?+
Often yes. A very recent diagnosis is commonly postponed because there is no stable track record to assess. Two or more years of documented stability usually produces a materially better offer than applying immediately.
Does being on disease-modifying therapy hurt my application?+
No, it generally helps. Being on treatment and stable is read as active management of the condition. What underwriters price is your relapse pattern and function, not the fact that you take medication.